Details of the Drug Reposition

General Information of This Drug (ID: DMPIHLS)

Drug Name
Diclofenac   DMPIHLS
Synonyms Diclofenac (sodium matrix patch, pain)
Therapeutic Class
Neurology Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Osteoarthritis DIS05URM FA00-FA05 Approved [1]
Knee osteoarthritis DISLSNBJ FA01 Approved [2]
Dysmenorrhea DISMYBW9 GA34.3 Approved [2]
Chronic renal failure DISGG7K6 GB61.Z Approved [2]
Pain DIS4RWOW MG30-MG3Z Approved [2]
------------------------------------------------------------------------------------
2 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rheumatoid arthritis DISTSB4J FA20 Discontinued in Phase 2 [3]
Ankylosing spondylitis DISRC6IR FA92.0 Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
1 Discontinued in Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Actinic keratosis DISR1RC5 EK90.0 Discontinued in Phase 1 [5]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Diclofenac FDA Label
3 Pramipexole ER vs. Placebo in Fibromyalgia
4 Sunitinib in Treating Patients With Idiopathic Myelofibrosis
5 ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma